Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 Mar;66(773):186–190. doi: 10.1136/pgmj.66.773.186

The natural history of euthyroid multinodular goitre.

J W Elte 1, J K Bussemaker 1, A Haak 1
PMCID: PMC2429462  PMID: 2114018

Abstract

In this communication data on the natural history of euthyroid multinodular goitres are presented. From a total group of 140 patients (mean age 54.6 years, 14 men and 126 women; 88 with autonomous, 52 with non-autonomous function), follow-up data were available for 90 patients (mean age 54.0 years, 11 men and 79 women; 64 with autonomous, 26 with non-autonomous function). During follow-up (means: 5.0 years, maximum 12.2 years) transitions in function were seen 15 times; 8 autonomous patients became hyperthyroid after less than 1-7 years. There were 6 transitions from non-autonomy to autonomy and 1 from autonomy to non-autonomy. One patient who demonstrated the whole cycle from non-autonomy through autonomy up to hyperthyrodism is described in more detail. In one patient operated upon because of hyperparathyroidism a follicular carcinoma was found by chance. Mechanical problems were the reason for surgery in 6 patients only, 16 patients were operated upon because of cosmetic reasons (mostly in the early years of the study). Finally, results from 19 TRH tests in 16 autonomous patients suggest that TRH tests in patients with autonomously functioning euthyroid multinodular goitres are not yet redundant.

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belfiore A., Sava L., Runello F., Tomaselli L., Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metab. 1983 Feb;56(2):283–287. doi: 10.1210/jcem-56-2-283. [DOI] [PubMed] [Google Scholar]
  2. Blum M., Shenkman L., Hollander C. S. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am J Med Sci. 1975 Jan-Feb;269(1):43–50. doi: 10.1097/00000441-197501000-00006. [DOI] [PubMed] [Google Scholar]
  3. Bondeson L., Ljungberg O. Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer. 1981 Jan 15;47(2):319–323. doi: 10.1002/1097-0142(19810115)47:2<319::aid-cncr2820470218>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  4. Carayon P., Martino E., Bartalena L., Grasso L., Mammoli C., Costagliola S., Pinchera A. Clinical usefulness and limitations of serum thyrotropin measurement by 'ultrasensitive' methods. Comparisons of five kits. Horm Res. 1987;26(1-4):105–117. doi: 10.1159/000180689. [DOI] [PubMed] [Google Scholar]
  5. Elte J. W., Haak A., Frölich M., Wiarda K. S., van Wermeskerken R. K. Autonomously functioning euthyroid multinodular goitre. Neth J Med. 1977;20(1):1–4. [PubMed] [Google Scholar]
  6. Emrich D., Bähre M. Autonomy in euthyroid goitre: maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 1978 Mar;8(3):257–265. doi: 10.1111/j.1365-2265.1978.tb01502.x. [DOI] [PubMed] [Google Scholar]
  7. Gemsenjäger E., Heitz P. U., Staub J. J., Girard J. Thyrotropin secretion in carcinoma of the thyroid. Surg Gynecol Obstet. 1980 Aug;151(2):205–208. [PubMed] [Google Scholar]
  8. Hamburger J. I. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab. 1980 Jun;50(6):1089–1093. doi: 10.1210/jcem-50-6-1089. [DOI] [PubMed] [Google Scholar]
  9. Hamburger J. I., Hamburger S. W. Diagnosis and management of large toxic multinodular goiters. J Nucl Med. 1985 Aug;26(8):888–892. [PubMed] [Google Scholar]
  10. Hamburger J. I. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med. 1975 Jun;58(6):740–748. doi: 10.1016/0002-9343(75)90630-0. [DOI] [PubMed] [Google Scholar]
  11. Hamburger J. I., Taylor C. I. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med. 1979 Sep;91(3):406–409. doi: 10.7326/0003-4819-91-3-406. [DOI] [PubMed] [Google Scholar]
  12. Kerr D. J., Alexander W. D. Is the TRH test usually unnecessary? Lancet. 1984 Nov 17;2(8412):1161–1162. doi: 10.1016/s0140-6736(84)91603-9. [DOI] [PubMed] [Google Scholar]
  13. Kirkegaard C., Bregengard C. Is the TRH test necessary? Lancet. 1985 Jan 26;1(8422):222–222. doi: 10.1016/s0140-6736(85)92058-6. [DOI] [PubMed] [Google Scholar]
  14. Lerro S., Losa M., Trisorio M. T., Liuzzi A. Free thyroid hormone levels and TSH response to TRH in patients with autonomous thyroid adenomata and normal T3 and T4. Clin Endocrinol (Oxf) 1985 Oct;23(4):373–378. doi: 10.1111/j.1365-2265.1985.tb01094.x. [DOI] [PubMed] [Google Scholar]
  15. McCall A., Jarosz H., Lawrence A. M., Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery. 1986 Dec;100(6):1128–1132. [PubMed] [Google Scholar]
  16. Miller J. M., Block M. A. Functional autonomy in multinodular goiter. JAMA. 1970 Oct 19;214(3):535–539. [PubMed] [Google Scholar]
  17. Parker J. L., Ratcliffe J. G., Alexander W. D. Sporadic non-toxic goitre. A long-term follow-up of 36 patients. Acta Endocrinol (Copenh) 1977 Jul;85(3):497–507. [PubMed] [Google Scholar]
  18. SOKAL J. E. A long-term follow-up of nontoxic nodular goiter; effect of clinical selection on the observed incidence of malignancy. AMA Arch Intern Med. 1957 Jan;99(1):60–69. doi: 10.1001/archinte.1957.00260010062009. [DOI] [PubMed] [Google Scholar]
  19. Seth J., Kellett H. A., Caldwell G., Sweeting V. M., Beckett G. J., Gow S. M., Toft A. D. A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotrophin releasing hormone test? Br Med J (Clin Res Ed) 1984 Nov 17;289(6455):1334–1336. doi: 10.1136/bmj.289.6455.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smeulers J., Docter R., Visser T. J., Hennemann G. Acute thyrotoxicosis in multinodular goitre. Neth J Med. 1977;20(6):275–277. [PubMed] [Google Scholar]
  21. Smeulers J., Docter R., Visser T. J., Hennemann G. Response to thyrotrophin-releasing hormone and triiodothyronine suppressibility in euthyroid multinodular goitre. Clin Endocrinol (Oxf) 1977 Nov;7(5):389–397. doi: 10.1111/j.1365-2265.1977.tb03348.x. [DOI] [PubMed] [Google Scholar]
  22. Smeulers J., Visser T. J., Docter R., Hennemann G. Occasional thyroxine and triiodothyronine hypersecretion in euthyroid multinodular goitre. Neth J Med. 1980;23(4):152–154. [PubMed] [Google Scholar]
  23. Studer H., Peter H. J., Gerber H. Toxic nodular goitre. Clin Endocrinol Metab. 1985 May;14(2):351–372. doi: 10.1016/s0300-595x(85)80038-4. [DOI] [PubMed] [Google Scholar]
  24. Vander J. B., Gaston E. A., Dawber T. R. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968 Sep;69(3):537–540. doi: 10.7326/0003-4819-69-3-537. [DOI] [PubMed] [Google Scholar]
  25. Wiener J. D., Frensdorf E. L. Thyroid autonomy (Plummer's disease) with contralateral malignancy--mere coincidence? Acta Med Scand. 1976;200(6):509–512. doi: 10.1111/j.0954-6820.1976.tb08274.x. [DOI] [PubMed] [Google Scholar]
  26. Wiener J. D. Long-term follow-up in untreated Plummer's disease (autonomous goiter). Clin Nucl Med. 1987 Mar;12(3):198–203. doi: 10.1097/00003072-198703000-00008. [DOI] [PubMed] [Google Scholar]
  27. Wiener J. D., de Vries A. A. On the natural history of Plummer's disease. Clin Nucl Med. 1979 May;4(5):181–190. doi: 10.1097/00003072-197905000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES